Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

Christine Erikstrup Hallgreen; Hendrika A. van den Ham; Shahrul Mt-Isa; Simon Ashworth; Richard Hermann; Steve Hobbiger; Davide Luciani; Alain Micaleff; Andrew Thomson; Nan Wang; Tjeerd P. van Staa; Gerald Downey; Ian Hirsch; Kimberley Hockley; Juhaeri Juhaeri; Marilyn Metcalf; Jeremiah Mwangi; Richard Nixon; Ruth Peters; Isabelle Stoeckert; Ed Waddingham; Ioanna Tzoulaki; Deborah Ashby; Lesley Wise

doi:10.1002/pds.3676

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

Christine Erikstrup Hallgreen, Hendrika A. van den Ham, Shahrul Mt-Isa, Simon Ashworth, Richard Hermann, Steve Hobbiger, Davide Luciani, Alain Micaleff, Andrew Thomson, Nan Wang, Tjeerd P. van Staa, Gerald Downey, Ian Hirsch, Kimberley Hockley, Juhaeri Juhaeri, Marilyn Metcalf, Jeremiah Mwangi, Richard Nixon, Ruth Peters, Isabelle StoeckertEd Waddingham, Ioanna Tzoulaki, Deborah Ashby, Lesley Wise

16 Citations (Scopus)

Original language	English
Journal	Pharmacoepidemiology and Drug Safety
Volume	23
Issue number	9
Pages (from-to)	974-983
Number of pages	10
ISSN	1053-8569
DOIs	https://doi.org/10.1002/pds.3676
Publication status	Published - Sept 2014
Externally published	Yes

Keywords

benefit-risk
decision making
medicines
qualitative
quantitative
warfarin
pharmacoepidemiology

Access to Document

10.1002/pds.3676

Cite this

Hallgreen, C. E., van den Ham, H. A., Mt-Isa, S., Ashworth, S., Hermann, R., Hobbiger, S., Luciani, D., Micaleff, A., Thomson, A., Wang, N., van Staa, T. P., Downey, G., Hirsch, I., Hockley, K., Juhaeri, J., Metcalf, M., Mwangi, J., Nixon, R., Peters, R., ... Wise, L. (2014). Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology. Pharmacoepidemiology and Drug Safety, 23(9), 974-983. https://doi.org/10.1002/pds.3676

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology. / Hallgreen, Christine Erikstrup; van den Ham, Hendrika A.; Mt-Isa, Shahrul et al.
In: Pharmacoepidemiology and Drug Safety, Vol. 23, No. 9, 09.2014, p. 974-983.

Research output: Contribution to journal › Journal article › Research › peer-review

Hallgreen, CE, van den Ham, HA, Mt-Isa, S, Ashworth, S, Hermann, R, Hobbiger, S, Luciani, D, Micaleff, A, Thomson, A, Wang, N, van Staa, TP, Downey, G, Hirsch, I, Hockley, K, Juhaeri, J, Metcalf, M, Mwangi, J, Nixon, R, Peters, R, Stoeckert, I, Waddingham, E, Tzoulaki, I, Ashby, D & Wise, L 2014, 'Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology', Pharmacoepidemiology and Drug Safety, vol. 23, no. 9, pp. 974-983. https://doi.org/10.1002/pds.3676

@article{333688867e634e66a62895bbe618a559,

title = "Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology",

keywords = "benefit-risk, decision making, medicines, qualitative, quantitative, warfarin, pharmacoepidemiology",

author = "Hallgreen, {Christine Erikstrup} and {van den Ham}, {Hendrika A.} and Shahrul Mt-Isa and Simon Ashworth and Richard Hermann and Steve Hobbiger and Davide Luciani and Alain Micaleff and Andrew Thomson and Nan Wang and {van Staa}, {Tjeerd P.} and Gerald Downey and Ian Hirsch and Kimberley Hockley and Juhaeri Juhaeri and Marilyn Metcalf and Jeremiah Mwangi and Richard Nixon and Ruth Peters and Isabelle Stoeckert and Ed Waddingham and Ioanna Tzoulaki and Deborah Ashby and Lesley Wise",

year = "2014",

month = sep,

doi = "10.1002/pds.3676",

language = "English",

volume = "23",

pages = "974--983",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "JohnWiley & Sons Ltd",

number = "9",

}

TY - JOUR

T1 - Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

AU - Hallgreen, Christine Erikstrup

AU - van den Ham, Hendrika A.

AU - Mt-Isa, Shahrul

AU - Ashworth, Simon

AU - Hermann, Richard

AU - Hobbiger, Steve

AU - Luciani, Davide

AU - Micaleff, Alain

AU - Thomson, Andrew

AU - Wang, Nan

AU - van Staa, Tjeerd P.

AU - Downey, Gerald

AU - Hirsch, Ian

AU - Hockley, Kimberley

AU - Juhaeri, Juhaeri

AU - Metcalf, Marilyn

AU - Mwangi, Jeremiah

AU - Nixon, Richard

AU - Peters, Ruth

AU - Stoeckert, Isabelle

AU - Waddingham, Ed

AU - Tzoulaki, Ioanna

AU - Ashby, Deborah

AU - Wise, Lesley

PY - 2014/9

Y1 - 2014/9

KW - benefit-risk

KW - decision making

KW - medicines

KW - qualitative

KW - quantitative

KW - warfarin

KW - pharmacoepidemiology

U2 - 10.1002/pds.3676

DO - 10.1002/pds.3676

M3 - Journal article

C2 - 25043919

SN - 1053-8569

VL - 23

SP - 974

EP - 983

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 9

ER -

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

Keywords

Access to Document

Fingerprint

Cite this